)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Pila Pharma
Pila Pharma (PILA) investor relations material
Pila Pharma H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary27 Aug, 2026
Executive summary
Regulatory approval received for a 12-week clinical trial (PP-CT04) of XEN-D0501 in obesity, marking a significant step in clinical development.
Focus remains on advancing TRPV1 antagonist for obesity, diabetes, and rare disease erythromelalgia.
The company operates virtually, relying on consultants and CROs for R&D activities.
Financial highlights
Operating income was TSEK 0, down from TSEK 851 in the same period last year.
EBIT for the first half was TSEK -3,850, an improvement from TSEK -4,092 year-over-year.
Net result for the period was TSEK -3,867, compared to TSEK -4,102 year-over-year.
Cash flow from operating activities was TSEK -17,974, including a TSEK 13,195 transfer to the Danish subsidiary.
Cash at period end: TSEK 3,257 (parent) and TSEK 10,126 (Danish subsidiary).
Outlook and guidance
The new clinical trial aims to establish safety and efficacy at higher doses and longer durations, potentially enabling further studies in obesity and related diseases.
No explicit financial or revenue guidance provided for the remainder of the year.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Pila Pharma
- Strategic refocus, strong financing, and clinical trial preparations mark 2025.PILA
H2 2025 - Strong rights issue funding supports new obesity drug focus, with preclinical results due by early 2026.PILAH1 2025
- Oral TRPV1 drug for diabetes and obesity advances, with new funding and pivotal studies ahead.PILAInvestor Update
- Preparing a dose escalation trial for diabetes/obesity, with expanded pipeline and active investor outreach.PILAInvestor Update
- SEK 10M raised, Phase 2a trial prep, new CEO, improved results, and rising investor interest.PILAH1 2024
- R&D and funding ramped up for a unique obesity drug, with stable liquidity and net loss.PILAH2 2024
Next Pila Pharma earnings date
H2 202625 Feb, 2027
Pila Pharma
Next Pila Pharma earnings date
H2 202625 Feb, 2027
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage